Skip to main content
FHTX logo
FHTX
(NASDAQ)
Foghorn Therapeutics Inc.
$4.93-- (--)
Loading... - Market loading

Foghorn Therapeutics (FHTX) Stock Price & Financial Analysis

Foghorn Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.70 - $5.03
52-Week High$6.95
52-Week Low$2.95
Open$4.75
Volume87.66K
Average Volume (3M)87.66K
Market Cap310.50M
Shares Outstanding62.98M
Price to Sales (P/S)9.98
EV/EBITDA-2.92
Revenue (TTM)30.91M
Net Income (TTM)-74.28M
Free Cash Flow (TTM)-86.15M
EPS (TTM)$-1.18
Profit Margin-240.33%
Operating Margin-279.49%
50-Day MA$5.44
200-Day MA$5.09
52-Week Change45.19%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Foghorn Therapeutics

What is the current stock price for FHTX?

As of the latest trading session, FHTX stock trades at $4.93. The 52-week range is $2.95–$6.95, with a day range of $4.70–$5.03.

What is the P/E ratio for FHTX?

The P/E ratio (Price-to-Earnings) for FHTX is shown in the Key Statistics section. This valuation metric helps compare Foghorn Therapeutics Inc. to industry peers.

Does FHTX pay dividends?

Foghorn Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for FHTX?

Based on 3 analysts, the consensus for FHTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of FHTX?

Foghorn Therapeutics's market capitalization is $310.5M, classifying it as a small-cap company. Foghorn Therapeutics operates in the Healthcare sector within the Biotechnology industry.